Open AccessCirculating annexin A2 as a biomarker in patients with pancreatic cancer
Author(s) -
Mehmet Karabulut,
Çiğdem Usul Afşar,
Murat Serilmez,
Senem Karabulut
Publication year - 2020
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_755_18
Subject(s) - medicine , gastroenterology , malignancy , pancreatic cancer , biomarker , cancer , confidence interval , metastasis , chemotherapy , oncology , annexin a2 , pathology , annexin , biology , staining , biochemistry
Pancreatic cancer (PC) is a highly lethal malignancy. There are only few predictive or prognostic markers for PC. This study was conducted to investigate the serum levels of annexin A2 (AnxA2) in patients with PC and its relationship with tumor progression and known prognostic parameters.